You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

I am a:
${ profile.name.substring(0, profile.name.length - 1) }
Request Info
Xpert Xpress SARS-CoV-2 Test

News Releases

Cepheid Announces Analyst Event And Webcast

SUNNYVALE, Calif., June 9, 2015 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that the company will host a Financial Analyst Event on Monday, July 27 th at the 2015 AACC Meeting being held July 26 th to 30th in Atlanta, GA.

The meeting will feature presentations and Q&A sessions with Cepheid's executive management team, and include a review of Cepheid's oncology program, the annual update of the company's five year test menu pipeline, and other subjects.  Meeting registration is now open to institutional investors and analysts.

 

When

4pm ET on Monday, July 27th

Where

Omni Atlanta Hotel at CNN Center

RSVP

investor.relations@cepheid.com

Interested parties unable to attend in person are invited to access the live webcast starting at 4 p.m. Eastern Time on Monday, July 27 th.  To access the webcast, please visit Cepheid's website at http://ir.cepheid.com.  A replay of the webcast will be available shortly following the event and will remain available for at least 90 days.

About Cepheid

Based in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy to use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to access the full power of molecular diagnostics. The company's systems enable rapid, sophisticated testing solutions for infectious diseases, oncology, and genetic conditions by automating otherwise complex manual laboratory procedures. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit www.cepheid.com.

For Cepheid Media & Investor Inquiries:
Jacquie Ross, CFA
 Cepheid Corporate Communications & Investor Relations
 408-400-8329
 corporate.communications@cepheid.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cepheid-announces-analyst-event-and-webcast-300095930.html

SOURCE Cepheid

Back to Top